Monoarylamines in the general population - A cross-sectional population-based study including 1004 Bavarian subjects

International Journal of Hygiene and Environmental Health

Volumn 212, Issue 3, 2009, Pages 298-309

  Kütting, Birgitta ^a   Göen, Thomas ^a   Schwegler, Ursula ^b   Fromme, Hermann ^b   Uter, Wolfgang ^a   Angerer, Jürgen ^a   Drexler, Hans ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b BAVARIAN HEALTH AND FOOD SAFETY AUTHORITY   (Germany)

Author keywords

Carcinogenicity; General population; Monoarylamines; Reference values

Indexed keywords

2 ANISIDINE; 2 TOLUIDINE; 2-ANISIDINE; 2-TOLUIDINE; AMINE; ANILINE; ANILINE DERIVATIVE; CARCINOGEN; HAIR DYE; PESTICIDE; TOLUIDINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; CROSS-SECTIONAL STUDY; DIET; ENVIRONMENTAL EXPOSURE; FEMALE; GERMANY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD; QUESTIONNAIRE; SEX DIFFERENCE; SMOKING; URINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINES; ANILINE COMPOUNDS; CARCINOGENS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIET; ENVIRONMENTAL EXPOSURE; FEMALE; GERMANY; HAIR DYES; HUMANS; MALE; MIDDLE AGED; PESTICIDES; QUESTIONNAIRES; SEX FACTORS; SMOKING; TOLUIDINES; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 62649151804     PISSN: 14384639     EISSN: 1618131X     Source Type: Journal    
DOI: 10.1016/j.ijheh.2008.07.004     Document Type: Article

References (49)

1. Ahlström L.H., Sparr Eskilsson C., and Björlund E. Determination of banned azo dyes in consumer goods. Trends Anal. Chem. 24 (2005) 49-56
2. Bartsch H., Malaveille C., Friesen M., Kadlubar F.F., and Vineis P. Black (air cured) and blond (flue cured) tobacco - cancer risk IV: molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur. J. Cancer 29A (1993) 1199-1207
3. Bolt H.M., and Golka K. The debate on carcinogenicity of permanent hair dyes: new insights. Crit. Rev. Toxicol. 37 (2007) 521-536
4. Bryant M.S., Skipper P.L., Tannenbaum S.R., and Maclure M. Hemoglobin adducts of 4-aminodiphenyl in smokers and non-smokers. Cancer Res. 47 (1987) 602-608
5. Bryant M.S., Simmons H.F., Harrell R.E., and Hinson J.A. 2,6-Dimethylaniline-hemoglobin adducts from lidocaine in humans. Carcinogenesis 15 (1994) 2287-2290
6. Castelao J.E., Yuan J.M., Skipper P.L., Tannenbaum S.R., Gago-Dominguez M., Crowder J.S., Ross R.K., and Yu M.C. Gender- and smoking related bladder cancer risk. J. Natl. Cancer Inst. (Bethesda) 93 (2001) 538-545
7. Cheever K.L., Richards D.E., and Plotnick H.B. Metabolism of ortho-, meta-, and para-toluidine in the adult male rat. Toxicol. Appl. Pharmacol. 56 (1980) 361-369
8. Coghlin J., Gann P.H., Hammond K., Skipper P., Taghizadeh K., Paul M., and Tannenbaum S.R. 4-Aminobiphenyl haemoglobin adducts in foetuses exposed to the tobacco smoke carcinogen in utero. J. Natl. Cancer Inst. 82 (1991) 274-280
9. Delclos K.B., and Kadlubar F.F. Carcinogenic aromatic amines and amides. In: Bowden G.T., and Fisher S.M. (Eds). Comprehensive Toxicology, vol. 12. Chemical Carcinogens and Anticarcinogens (1997), Elsevier Science, New York, NY 141-170
10. DFG German Research Foundation, 2007. MAK- and BAT-values. Report no. 43, VCH Verlagsgesellschaft, Weinheim.
11. El-Bayoumi K., Donahue J.M., Hecht S.S., and Hoffmann D. Identification and quantitative determination of aniline and o-toluidines in human urine. Cancer Res. 46 (1986) 6064-6067
12. Falter B., Kutzer C., and Richter E. Biomonitoring of haemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72 (1994) 364-371
13. Gan J., Skipper P.L., Gago-Dominguez M., Arakawa K., Ross R.K., Yu M.C., and Tannenbaum S.R. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J. Natl. Cancer Inst. 96 (2004) 1425-1431
14. Gago-Dominguez M., Castelao J.E., Yuan J.M., Yu M.C., and Ross R.K. Use of permanent hair dyes and bladder-cancer risk. Int. J. Cancer 91 (2001) 575-579
15. Gago-Dominguez M., Chan K.K., Ross R.K., and Yu M.C. Permanent hair dyes and bladder-cancer risk. Int. J. Cancer 94 (2001) 905-906
16. Gago-Dominguez M., Bell D.A., Watson M.A., Yuan J.M., Castelao J.E., Hein D.W., et al. Permanent hair dyes and bladder cancer: risk modification by cytochrome p450 1A2 and N-acetyltransferases 1 and 2. Carcinogenesis 24 (2003) 483-489
17. Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish bladder cancer study and meta-analyses. Lancet 366 (2005) 649-659
18. Golka K., Prior V., Blaszkewicz M., and Bolt H.M. The enhanced bladder cancer susceptibility of NAT2 slow aceylators towards aromatic amines: a review considering ethnic differences. Toxicol. Lett. 128 (2002) 229-241
19. Gorrod J.W., and Manson D. The metabolism of aromatic amines. Xenobiotica 16 (1986) 933-955
20. Gu J., Liang D., Wang Y., Lu C., and Wu X. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in caucasians. Mutat. Res. 581 (2005) 97-104
21. International Agency for Research on Cancer (IARC), 2002. Tobacco Smoking and Involuntary Smoking. IARC Monographs on Evaluation of Risks for Chemicals to Humans, vol. 38. IARC, Lyon, France.
22. Kao J., Faukner J., and Bridges J.W. Metabolism of aniline in rats, pigs and sheep. Drug Metab. Dispos. 6 (1978) 549-555
23. Kogevinas M., Fernandez F., Garcia-Closas M., Tardon A., Garcia-Closas R., Serra C., Carrato A., Castano-Vinyals G., Yeager M., Chanock S.J., Lloreta J., Rothman N., Real F.X., Dosemici M., Malats N., and Silverman D. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur. J. Cancer 42 (2006) 1448-1454
24. Kütting B., Schettgen T., Beckmann M., Angerer J., and Drexler H. Influence of diet on exposure to acrylamide - reflections on the validity of a questionnaire. Ann. Nutr. Metab. 49 (2005) 173-177
25. Kütting B., Uter W., and Drexler H. The association between self-reported acrylamide intake and hemoglobin adducts as biomarker of exposure. Cancer Causes Control 19 (2008) 273-281 (Epub November 6 2007)
26. Lubin J.H., Kogevinas M., Silverman D., Malats N., Garcia-Closas M., Tardón A., et al. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish bladder cancer study. Int. J. Epidemiol 36 (2007) 236-241
27. MacLure M., Katz R.B.A., Bryant M.S., Skipper P.L., and Tannenbaum S.R. Elevated blood levels of carcinogens in passive smokers. Am. J. Publ. Health 79 (1989) 1381-1384
28. Murphy, J., Jacobs, K., 1975. Residues of Rompun and its metabolites in cattle. Bayer Study Report no. 43814, Bayer AG, Leverkusen, Germany, available at: 〈http://www.fao.org/docrep/W4601E/w461eof.htm〉.
29. Putter J., and Sagner G. Chemical studies to detect residues of xylazine hydrochloride. Vet. Med. Rev. 2 (1973) 145-159
30. Richter E., and Branner B. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J. Chromatogr. B 778 (2002) 49-62
31. Richter E., and Sabbioni G. Aromatic amines. In: Marquardt H., Schäfer S., McClellan R.O., and Welsch F. (Eds). Toxicology (1999), Academic Press, New York 729-741
32. Riedel K., Scherer G., Engl J., Hagedorn H.W., and Tricher A.R. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J. Anal. Toxicol. 30 (2006) 187-195
33. Riffelmann M., Müller G., Schmieding W., Popp W., and Norpoth K. Biomonitoring of urinary aromatic amines and arylamine haemoglobin adducts in exposed workers and non-exposed control persons. Int. Arch. Occup. Environ. Health 68 (1995) 36-43
34. Schettgen T., Weiss T., Drexler H., and Angerer J. A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. Int. J. Hyg. Environ. Health 206 (2003) 9-14
35. Schettgen T., Rossbach B., Kütting B., Letzel S., Drexler H., and Angerer J. Determination of hemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int. J. Hyg. Environ. Health 207 6 (2004) 531-539
36. Skipper P.l., Tannenbaum S.R., Ross R.K., and Yu M.C. Non-smoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 503-507
37. Sorahan T., Hamilton l., and Jackson J.R. A further cohort study of workers employed at a factory manufacturing chemicals for the rubber industry, with special reference to the chemicals 2-mercaptobenzothiazole (MBT), aniline, phenyl-β-napthylamine and o-toluidine. Occup. Environ. Med. 57 (2000) 106-115
38. Teass A.W., De Bord D.G., Brown K.K., Cheever K.L., Stettler L.E., Savage R.E., Weigel W.W., Dankovic D., and Ward E. Biological monitoring for occupational exposures to o-toluidine and aniline. Int. Arch. Occup. Environ. Health 65 (1993) S115-S118
39. Tworoger S.S., and Hankinson S.E. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17 (2006) 889-899
40. Vineis P. Epidemiological models of carcinogenesis: the example of bladder cancer. Cancer Epidemiol. Biomarkers Prev. 1 (1992) 149-153
41. Vineis P. The use of biomarkers in epidemiology: the example of bladder cancer. Toxicol. Lett. 64/65 (1992) 463-467
42. Vineis P. Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect. 102 Suppl. 6 (1994) 7-10
43. Vineis P., and Pirastu R. Aromatic amines and cancer. Cancer Causes Control 8 (1997) 346-355
44. Ward E., Carpenter A., Markowitz S., Roberts D., and Halperin W. Excess number of bladder cancers in workers exposed to ortho-toluidine and aniline. J. Natl. Cancer Inst. 83 (1991) 501-506
45. Ward E.M., Sabbioni G., De Bord G., Teass A.W., Brown K.K., Talaska G.G., Roberts D.R., Ruder A.M., and Streicher R.P. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder excess. J. Natl. Cancer Inst. 88 (1996) 1046-1052
46. Weiss T., and Angerer J. Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J. Chromatogr. B (2002) 179-192
47. Weiss T., Ewers U., Flieger A., and Angerer J. Innere Belastung der Allgemeinbevölkerung mit Amino- und nitroaromatischen Verbindungen. Umweltmed. Forsch. Prax. 5 (2000) 101-106
48. Yu M., Skipper P.L., Taghizadeh K., Tannenbaum S.R., Chan K.K., Henderson B.E., and Ross R.K. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J. Natl. Cancer Inst. 86 (1994) 712-716
49. Yu M.C., Skipper P.L., Tannenbaum S.R., Chan K.K., and Ross R.K. Arylamine exposure and bladder cancer risk. Mutat. Res. 506-507 (2002) 21-28